StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report report published on Wednesday. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens lifted their price target on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, January 31st.
View Our Latest Report on Veradigm
Veradigm Stock Down 7.0 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- Stock Splits, Do They Really Impact Investors?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What is the Nikkei 225 index?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Profitably Trade Stocks at 52-Week Highs
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
